Your Article Summary
See Latest ArticlesLong-Term Follow-up of 100 High-Risk Renal Transplant Recipients Converted From Calcineurin Inhibitors to Sirolimus: A Single Center Experience
Transplantation Proceedings, 07/02/09
Halim MA et al. - Conversion from CNI to SRL was effective among high-risk RTR, but with a high incidence of adverse events during long-term follow-up.
Related Articles
A Phase I Study of the Mammalian Target of Rapamycin Inhibitor Sirolimus and MEC Chemotherapy in Relapsed and Refractory Acute Myelogenous Leukemia
Clinical Cancer Research, 10/26/09
Relevance Score: 88%
Current Approaches to the Use of Sirolimus In Renal Transplantation
Transplantation Proceedings, 11/05/09
Relevance Score: 87%
Combined treatment with cisplatin and sirolimus to enhance cell death in human mesothelioma
The Journal of Thoracic and Cardiovascular Surgery, 10/27/09
Relevance Score: 87%
Multiple coronary artery aneurysm formation one year and four years after sirolimus-eluting coronary stent implantation
Cardiovascular Revascularization Medicine, 10/16/09
Relevance Score: 84%
Resolution of late sirolimus-eluting stent thrombosis after tirofiban treatment
Heart and Vessels, 10/07/09
Relevance Score: 84%
Today in Transplantation...keeping you current
Receive free subspecialty "5-minute updates" via email
Prevalence and predictors of recurrent IgA nephropathy following renal transplantation
Irish Journal of Medical Science, 12/18/09
Renal Function Outcomes in Kidney Transplant Recipients After Conversion to Everolimus-Based Immunosuppression Regimen with CNI Reduction or Elimination
Transplantation Proceedings, 12/18/09
Late Acute Kidney Transplant Rejection: Clinicopathological Correlates and Response to Corticosteroid Therapy
Transplantation Proceedings, 12/18/09